Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 1
2006 4
2007 13
2008 3
2009 1
2010 4
2011 15
2012 8
2013 8
2014 14
2015 18
2016 12
2017 19
2018 15
2019 15
2020 20
2021 25
2022 40
2023 33
2024 30
2025 39
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Results by year

Filters applied: . Clear all
Page 1
Cyclin-dependent kinase 7 inhibitors in cancer therapy.
Wang M, Wang T, Zhang X, Wu X, Jiang S. Wang M, et al. Among authors: jiang s. Future Med Chem. 2020 May;12(9):813-833. doi: 10.4155/fmc-2019-0334. Epub 2020 Mar 25. Future Med Chem. 2020. PMID: 32208930 Review.
The development of small-molecule inhibitors targeting HPK1.
Zhou L, Wang T, Zhang K, Zhang X, Jiang S. Zhou L, et al. Among authors: jiang s. Eur J Med Chem. 2022 Dec 15;244:114819. doi: 10.1016/j.ejmech.2022.114819. Epub 2022 Oct 4. Eur J Med Chem. 2022. PMID: 36209628 Review.
Targeting tropomyosin receptor kinase for cancer therapy.
Miao Q, Ma K, Chen D, Wu X, Jiang S. Miao Q, et al. Among authors: jiang s. Eur J Med Chem. 2019 Aug 1;175:129-148. doi: 10.1016/j.ejmech.2019.04.053. Epub 2019 Apr 30. Eur J Med Chem. 2019. PMID: 31077998 Review.
317 results